OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus
Theresa S. Rimmele, Shaomin Li, Jens V. Andersen, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 24

Showing 24 citing articles:

Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle
Jens V. Andersen, Arne Schousboe, Alexei Verkhratsky
Progress in Neurobiology (2022) Vol. 217, pp. 102331-102331
Closed Access | Times Cited: 149

Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission — The essential roles of astrocytes
Jens V. Andersen, Arne Schousboe
Journal of Neurochemistry (2023) Vol. 166, Iss. 2, pp. 109-137
Open Access | Times Cited: 59

Glial Glutamine Homeostasis in Health and Disease
Jens V. Andersen, Arne Schousboe
Neurochemical Research (2022) Vol. 48, Iss. 4, pp. 1100-1128
Closed Access | Times Cited: 46

Oxoglutarate dehydrogenase complex controls glutamate-mediated neuronal death
Adelheid Weidinger, Nadja Milivojev, Arthur Hosmann, et al.
Redox Biology (2023) Vol. 62, pp. 102669-102669
Open Access | Times Cited: 25

Glutamatergic Neurotransmission in Aging and Neurodegenerative Diseases: A Potential Target to Improve Cognitive Impairment in Aging
Selma Karime Castillo-Vázquez, Lourdes Massieu, Ruth Rincón-Heredia, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103039-103039
Closed Access | Times Cited: 9

The Glutamate/GABA‐Glutamine Cycle: Insights, Updates, and Advances
Jens V. Andersen
Journal of Neurochemistry (2025) Vol. 169, Iss. 3
Open Access | Times Cited: 1

Common Signaling Pathways Involved in Alzheimer’s Disease and Stroke: Two Faces of the Same Coin
Tushar Kanti Das, Bhanu Priya Ganesh, Kaneez Fatima-Shad
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 381-398
Open Access | Times Cited: 16

Exposure to polystyrene nanoplastics causes anxiety and depressive-like behavior and down-regulates EAAT2 expression in mice
Ziyang Su, Rui Kong, Chengqing Huang, et al.
Archives of Toxicology (2025)
Closed Access

Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation
Osama A. Abulseoud, Fawaz Alasmari, Abdelaziz M. Hussein, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21

Asymmetric dysregulation of glutamate dynamics across the synaptic cleft in a mouse model of Alzheimer’s disease
Kyle J. Brymer, Emily P. Hurley, Jessica C. Barron, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 10

TSG-6 mediated extracellular matrix modifications regulate hypoxic-ischemic brain injury
Taasin Srivastava, Hung Nguyen, Gage Haden, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 21, pp. e2215232024-e2215232024
Closed Access | Times Cited: 2

Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine
Pankaj Kadyan, Lovedeep Singh
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 665-678
Closed Access | Times Cited: 2

Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs
Ana Cristina García-Gaytán, Andy Hernández-Abrego, Mauricio Díaz‐Muñoz, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 12

Inhibition of mGluR5 alters BDNF/TrkB and GLT-1 expression in the prefrontal cortex and hippocampus and ameliorates PTSD-like behavior in rats
Shuyue Cheng, Jingjing Xu, Wei Wang, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 837-851
Closed Access | Times Cited: 6

Stable isotope tracing reveals disturbed cellular energy and glutamate metabolism in hippocampal slices of aged male mice
Laura F. McNair, Jens V. Andersen, Helle S. Waagepetersen
Neurochemistry International (2023) Vol. 171, pp. 105626-105626
Open Access | Times Cited: 4

A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity
Giulio Bonifazi, Celia Luchena, Adhara Gaminde‐Blasco, et al.
Neurobiology of Disease (2024) Vol. 194, pp. 106473-106473
Open Access | Times Cited: 1

Common and divergent pathways in early stages of glutamate and tau-mediated toxicities in neurodegeneration
Anjalika Chongtham, Abhijeet Sharma, Banshi Nath, et al.
Experimental Neurology (2024) Vol. 382, pp. 114967-114967
Closed Access | Times Cited: 1

Deletion of CaMKIIα disrupts glucose metabolism, glutamate uptake, and synaptic energetics in the cerebral cortex
Jens V. Andersen, Emil W. Westi, Nane Griem‐Krey, et al.
Journal of Neurochemistry (2023) Vol. 168, Iss. 5, pp. 704-718
Open Access | Times Cited: 3

Glutamate Transporter 1 as a Novel Negative Regulator of Amyloid β
Priyanka Sinha, Yuliia Turchyna, Shane Mitchell, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1600-1600
Open Access

Acute astrocytic and neuronal regulation of glutamatergic protein expression following blast
Carly Norris, Susan Murphy, Pamela J. VandeVord
Neuroscience Letters (2024), pp. 138108-138108
Closed Access

Regulation of rat HspB5/alphaB-Crystallin by microRNAs miR-101a-3p, miR-140-5p, miR-330-5p, and miR-376b-3p
Britta Bartelt‐Kirbach, Nikola Golenhofen
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 787-799
Open Access

Page 1

Scroll to top